Clinical trial
Effects of Dapagliflozin on Hypotensive Patients With Depressed Left Ventricular Ejection Fraction After Sacubitril/Valsartan Therapy
NCT04575675 is registered in ClinicalTrials.gov with Cheng-Hsin General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Dapagliflozin on Hypotensive Patients With Depressed Left Ventricular Ejection Fraction After Sacubitril/Valsartan Therapy
- Lead sponsor
- Cheng-Hsin General Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 29, 2020
- Completion date
- December 30, 2020
- Enrollment
- 78 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.